New Technology CSWT Cardiac Shock Wave Therapy
What is CSWT?
CSWT, as known as cardiac shock wave therapy, is an effective and safe method in the treatment of coronary artery disease (CAD).
Coronary artery disease (CAD) is a heart disease caused by atherosclerosis of the coronary arteries, which leads to narrowing or occlusion of the blood vessels and further leads to ischemia, hypoxia or necrosis of the heart muscle.
CSWT is a non-invasive method of CAD treatment. It is widely used in many European countries, such as Switzerland, Germany and Italy, as well as in Asia.
The mechanism of action is to produce mechanical shear and cavitation effects in myocardial tissue cells, resulting in the production of nitric oxide (NO) and vascular endothelial growth factor (VEGF) locally in the myocardium.
More disease that CSWT can treat:
Chronic Refractory Angina Pectoris (CRAP)
Coronary Artery Disease (CAD)
Improves myocardial perfusion and ameliorates cardiac remodeling after acute myocardial infarction (AMI)
Promotes arteriogenesis of coronary micrangium and alleviate myocardial apoptosis and fibrosis after AMI
Non-revascularizable Angina Pectoris
Ischemic Heart Disease (HF)
No-reflow after PCI
Diffuse Coronary Artery Disease
Why CSWT is safe and non-invasive?
Cardiac shock wave therapy is a new development in cardiovascular therapy.
It is a non-invasive procedure that uses low-intensity shockwave to stimulate angiogenesis, or the development of new blood vessels. Further studies have indicated that the procedure appears to be safe for patients with refractory angina (a chronic condition characterized by angina pectoris).
The shock waves are tracked with ultrasound and placed through a membrane over the targeted treatment area.
The provider is able to see the target area through the ultrasound technology.